Telo Genomics has partnered with contract research organization Emery Pharma to put together their respective technologies to provide clinical R&D solutions for its pharmaceutical and diagnostics sector clients.
Through this collaboration, both Telo Genomics and Emery Pharma aim to enhance their capability to offer cellular and molecular bioanalytical solutions. Telo Genomics brings its proprietary TeloView platform, capable of identifying genomic instability, into the partnership, while Emery Pharma provides services such as mass analysis, peptide mapping, glycan analysis, post-translational modifications, immunogenicity analysis, and general R&D and good laboratory practice (GLP) support.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.